Back to Search Start Over

Mutations in TAF8 cause a neurodegenerative disorder

Authors :
Wong, Keit Men
Jepsen, Wayne M.
Efthymiou, Stephanie
Salpietro, Vincenzo
Sanchez-Castillo, Meredith
Yip, Janice
Kriouile, Yamna
Diegmann, Susann
Dreha-Kulaczewski, Steffi
Altmuller, Janine
Thiele, Holger
Nurnberg, Peter
Toosi, Mehran Beiraghi
Akhondian, Javad
Karimiani, Ehsan Ghayoor
Hummel-Abmeier, Hannah
Huppke, Brenda
Houlden, Henry
Gartner, Jutta
Maroofian, Reza
Huppke, Peter
Wong, Keit Men
Jepsen, Wayne M.
Efthymiou, Stephanie
Salpietro, Vincenzo
Sanchez-Castillo, Meredith
Yip, Janice
Kriouile, Yamna
Diegmann, Susann
Dreha-Kulaczewski, Steffi
Altmuller, Janine
Thiele, Holger
Nurnberg, Peter
Toosi, Mehran Beiraghi
Akhondian, Javad
Karimiani, Ehsan Ghayoor
Hummel-Abmeier, Hannah
Huppke, Brenda
Houlden, Henry
Gartner, Jutta
Maroofian, Reza
Huppke, Peter
Publication Year :
2022

Abstract

Wong et al. describe a severe neurodevelopmental disorder with progressive brain atrophy caused by variants in TAF8 coding for a subunit of the TFIID complex. Review of the literature reveals that loss of function mutations in other subunits of the TFIID complex are associated with similar phenotypes. TAF8 is part of the transcription factor II D complex, composed of the TATA-binding protein and 13 TATA-binding protein-associated factors (TAFs). Transcription factor II D is the first general transcription factor recruited at promoters to assemble the RNA polymerase II preinitiation complex. So far disorders related to variants in 5 of the 13 subunits of human transcription factor II D have been described. Recently, a child with a homozygous c.781-1G>A mutation in TAF8 has been reported. Here we describe seven further patients with mutations in TAF8 and thereby confirm the TAF8 related disorder. In two sibling patients, we identified two novel compound heterozygous TAF8 splice site mutations, c.45+4A > G and c.489G>A, which cause aberrant splicing as well as reduced expression and mislocalization of TAF8. In five further patients, the previously described c.781-1G > A mutation was present on both alleles. The clinical phenotype associated with the different TAF8 mutations is characterized by severe psychomotor retardation with almost absent development, feeding problems, microcephaly, growth retardation, spasticity and epilepsy. Cerebral imaging showed hypomyelination, a thin corpus callosum and brain atrophy. Moreover, repeated imaging in the sibling pair demonstrated progressive cerebral and cerebellar atrophy. Consistently, reduced N-acetylaspartate, a marker of neuronal viability, was observed on magnetic resonance spectroscopy. Further review of the literature shows that mutations causing a reduced expression of transcription factor II D subunits have an overlapping phenotype of microcephaly, developmental delay and intellectual disability. Although transcriptio

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1383745134
Document Type :
Electronic Resource